Abstract:Background and objective: Cognitive–behavioral therapy (CBT) for somatoform disorders (SFDs) is understudied in China. Western findings may not be applicable to Chinese culture. This preliminary study evaluated the efficacy of CBT for patients in China, relative to treatment-as-usual (TAU). Methods: Seventy patients with SFDs randomly received either combined CBT and TAU (CBT + TAU), or TAU alone between January 2018 to May 2019. The CBT + TAU group received 12 weekly individual 50-minute CBT sessions. Participants were blindly assessed at 4 timepoints (baseline, week 6, end of treatment: week 12; 12 weeks post-treatment: week 24) using the following outcome measures: SQSS (Self-screening Questionnaire for Somatic Symptoms); PHQ-15 (Patient-Health-Questionnaire-15) and the WI (Whiteley Index); GAD-7 (General Anxiety Disorder-7); HAMD-17 (Hamilton Depression Rating Scale-17); Family Burden Interview Schedule (FBIS); Sheehan Disability Scale (SDS); and the Short Form of Quality-of-Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q-SF). The primary endpoint was the difference between the SQSS total score at week 24 and the baseline. A mixed model for repeated measures was used to analyze inter- and intra-group changes from the baseline. Results: At week 24, The least-squares mean (LSM) change of the total score on the SQSS was −18.87 points and −9.69 points, respectively in the CBT + TAU group and in the TAU group (LSM difference, −9.18 points; 95% confidence interval, −15.72 to −2.64; P = 0.0068). At week 24, the LSM changes from baseline in the WI, HAMD, PHQ15, FBIS and SDS total scores were significantly different between the two groups, however, there was no significant difference in the Q-LES-Q-SF. The SQSS of group effect sizes were 0.63 at 24 weeks. The dropout rates of the CBT + TAU and TAU groups were comparable (22.9% and 19.3%). Conclusions: These preliminary findings suggest that CBT may be helpful for improving the symptoms of patients with SFDs in China.

A control study of duloxetine versus fluoxetine in the treatment of somatoform disorders

Clinical study of duloxetine in treatment of persistent somatoform pain disorder

A Controlled Study on Treatment of Alcohol Abuse with Trazodone and Furazolidone

Duloxetine Versus Paroxetine in the Treatment of Major Depressive Disorder: a Randomized Double-Blind Multicentre Controlled Study

Venlafaxine and sertraline in the treatment of somatoform disorders

Multi-center,randomized,and double-blind controlled clinical trial of duloxetine enteric capsule in treatment of depression

The efficacy and tolerability of duloxetine in the treatment of anxious versus non-anxious depression: a post-hoc analysis of an open-label outpatient study

Combination of Citalopram Plus Paliperidone is Better Than Citalopram Alone in the Treatment of Somatoform Disorder: Results of a 6-Week Randomized Study.

Frequency Of Treatment-Emergent Sexual Dysfunction And Treatment Effectiveness During Ssri Or Duloxetine Therapy: 8-Week Data From A 6-Month Observational Study

Efficacy of fluoxetine combined with psychological intervention for treatment of depressive patients with insomnia

Cognitive–behavioral therapy for patients with somatoform disorders: A pilot preliminary randomized controlled trial

Control study of mirtazapine and fluoxetine in therapy of depression

Treatment of Major Depressive Disorders with Generic Duloxetine and Paroxetine: a Multi-Centered, Double-Blind, Double-Dummy, Randomized Controlled Clinical Trial.

Comparison of the Effectiveness of Duloxetine in Depressed Patients with and Without a Family History of Affective Disorders in First-Degree Relatives.

Benefit of small dose antidepressants for functional dyspepsia: Experience from a tertiary center in eastern China.

A Preliminary Randomized Controlled Trial of Different Treatment Regimens for Melancholic Depression

A Control Study of Sertraline Combined with Buspar in Treatment of Refractory Obsessive-compulsive ;Disorder

A parallel control study of venlafaxine and fluoxertine in first-episode patients with depression

Short-course antidepressant therapy reduces discontinuation syndrome while maintaining treatment efficacy in patients with refractory functional dyspepsia: A randomized controlled trial

A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine

The efficacy and safety of trazodone plus fluoxetine in the treatment of male depression patients